New Alzheimer’s drug slows down disease by one-third.
After decades of failed attempts and research, scientists have finally found success in targeting amyloid as a way to slow down Alzheimer’s disease. This breakthrough came with the discovery of two drugs that specifically target amyloid in the brain, giving hope to millions of people who suffer from this debilitating disease.
The Dementia Research Institute in the UK, led by Dr. John Hardy, was the driving force behind the idea of targeting amyloid as a way to combat Alzheimer’s. Now, 30 years later, his team’s vision has been realized with the development of two drugs that can slow down the progression of the disease.
The discovery of these drugs has unleashed a wave of optimism in the medical community. Dr. Susan Kolhaas of Alzheimer’s Research UK commented that “it’s great that we have two drugs now,” acknowledging the significance of this breakthrough in the treatment of Alzheimer’s.
While these drugs do not cure Alzheimer’s, they offer a glimmer of hope for millions of people who suffer from this debilitating disease. The hunt for a cure is far from over, but the discovery of these drugs is a major step forward in the fight to find a treatment that can offer some relief to those suffering from Alzheimer’s.
